FLS Stock Analysis: Flowserve | NYSE
Specialty Industrial Machinery | NYSE, USA | Market Cap: 8.530m USD | 12M Return: 34.9% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 126M
EPS Trend: 97.7%
Qual. Beats: 0
Rev. Trend: 90.4%
Qual. Beats: -4
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Flowserve Corporation (NYSE: FLS) is a U.S.-based industrial manufacturer that designs, produces, distributes, and services flow management equipment for process industries worldwide. The company operates through two segments: the Flowserve Pumps Division (FPD) and the Flow Control Division (FCD).
Its product portfolio includes custom and pre-configured industrial pumps, mechanical seals (including gas-lubricated seals for pipelines), engineered and configured isolation and control valves, valve automation products, actuators, positioners, and switches. The company also provides a broad range of aftermarket services such as installation, commissioning, diagnostics, repair, retrofit, field machining, and asset management, sold under the Valtek, Argus, Worcester, Limitorque, and Durco brand names.
Flowserve serves end markets including oil and gas, power generation, chemical, water management, and general industrial sectors such as pharmaceuticals, mining, food and beverage, steel, and pulp and paper. Distribution is carried out through direct sales, third-party distributors, and independent sales representatives. The company is headquartered in Irving, Texas, and is classified within the Industrials sector (Industrial Machinery & Supplies & Components sub-industry).
As an industrial original equipment manufacturer, Flowserves business model combines project-based equipment sales with a recurring aftermarket service and spare parts stream tied to the installed base of pumps, seals, and valves across customer facilities.
- Oil prices and upstream capex lift pump demand
- Energy transition orders expand LNG hydrogen backlog
- Operational excellence program drives margin expansion
| Net Income: 354.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 3.35 > 1.0 |
| NWC/Revenue: 36.04% < 20% (prev 32.13%; Δ 3.91% < -1%) |
| CFO/TA 0.09 > 3% & CFO 512.7m > Net Income 354.0m |
| Net Debt (1.27b) to EBITDA (709.7m): 1.79 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (128.6m) vs 12m ago -3.05% < -2% |
| Gross Margin: 35.53% > 18% (prev 32.52%; Δ 3.01% > 0.5%) |
| Asset Turnover: 82.97% > 50% (prev 84.16%; Δ -1.20% > 0%) |
| Interest Coverage Ratio: 7.79 > 6 (EBIT TTM 614.6m / Interest Expense TTM 78.9m) |
| A: 0.29 (Total Current Assets 3.05b - Total Current Liabilities 1.38b) / Total Assets 5.73b |
| B: 0.75 (Retained Earnings 4.32b / Total Assets 5.73b) |
| C: 0.11 (EBIT TTM 614.6m / Avg Total Assets 5.61b) |
| D: 0.64 (Book Value of Equity 2.21b / Total Liabilities 3.45b) |
| Altman-Z'' = 5.78 = AAA |
| DSRI: 0.96 (Receivables 1.32b/1.36b, Revenue 4.65b/4.61b) |
| GMI: 0.92 (GM 32.52% / 35.53%) |
| AQI: 0.98 (AQ_t 0.34 / AQ_t-1 0.35) |
| SGI: 1.01 (Revenue 4.65b / 4.61b) |
| TATA: -0.03 (NI 354.0m - CFO 512.7m) / TA 5.73b) |
| Beneish M = -3.14 (Cap -4..+1) = AA |
As of July 26, 2026, the stock is trading at USD 72.40 with a total of 1,437,268 shares traded. Over the past week, the price has changed by +5.76%, over one month by -0.43%, over three months by -12.75% and over the past year by +34.91%.
Current recommended Stop Loss: 68.70 (which is 5.1% or 1.3 ATR below the current price).
Flowserve has received a consensus analysts rating of 4.55. Therefore, it is recommended to buy FLS.
- StrongBuy: 8
- Buy: 1
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 88.5 | 22.2% |
P/E Trailing = 25.2324
P/E Forward = 16.9492
P/S = 1.9683
P/B = 3.9625
P/EG = 1.6936
Revenue TTM = 4.65b USD
EBIT TTM = 614.6m USD
EBITDA TTM = 709.7m USD
Long Term Debt = 1.66b USD (from longTermDebt, last quarter)
Short Term Debt = 88.4m USD (from shortTermDebt, last quarter)
Debt = 2.07b USD (from shortLongTermDebtTotal, last quarter) + Leases 175.4m
Net Debt = 1.27b USD (calculated: Debt 2.07b - CCE 792.4m)
Enterprise Value = 9.80b USD (8.53b + Debt 2.07b - CCE 792.4m)
Interest Coverage Ratio = 7.79 (Ebit TTM 614.6m / Interest Expense TTM 78.9m)
EV/FCF = 22.45x (Enterprise Value 9.80b / FCF TTM 436.6m)
FCF Yield = 4.45% (FCF TTM 436.6m / Enterprise Value 9.80b)
FCF Margin = 9.38% (FCF TTM 436.6m / Revenue TTM 4.65b)
Net Margin = 7.61% (Net Income TTM 354.0m / Revenue TTM 4.65b)
Gross Margin = 35.53% ((Revenue TTM 4.65b - Cost of Revenue TTM 3.00b) / Revenue TTM)
Gross Margin QoQ = 37.10% (prev 35.94%)
Tobins Q-Ratio = 1.71 (Enterprise Value 9.80b / Total Assets 5.73b)
Interest Expense / Debt = 3.82% (Interest Expense 78.9m / Debt 2.07b)
Taxrate = 29.68% (159.0m / 535.7m)
NOPAT = 432.2m (EBIT 614.6m * (1 - 29.68%))
Current Ratio = 2.22 (Total Current Assets 3.05b / Total Current Liabilities 1.38b)
Debt / Equity = 0.93 (Debt 2.07b / totalStockholderEquity, last quarter 2.21b)
Debt / EBITDA = 1.79 (Net Debt 1.27b / EBITDA 709.7m)
Debt / FCF = 2.92 (Net Debt 1.27b / FCF TTM 436.6m)
Total Stockholder Equity = 2.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.31% (Net Income 354.0m / Total Assets 5.73b)
RoE = 15.93% (Net Income TTM 354.0m / Total Stockholder Equity 2.22b)
RoCE = 15.82% (EBIT 614.6m / Capital Employed (Equity 2.22b + L.T.Debt 1.66b))
RoIC = 10.26% (NOPAT 432.2m / Invested Capital 4.21b)
WACC = 10.23% (E(8.53b)/V(10.6b) * Re(12.06%) + D(2.07b)/V(10.6b) * Rd(3.82%) * (1-Tc(0.30)))
Discount Rate = 12.06% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -74.67 | Cagr: -1.19%
[DCF] Terminal Value 72.13% ; FCFF base≈355.6m ; Y1≈407.6m ; Y5≈599.9m
[DCF] Fair Price = 43.04 (EV 6.77b - Net Debt 1.27b = Equity 5.50b / Shares 127.8m; r=10.23% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 97.71 | EPS CAGR: 29.35% | SUE: 0.65 | # QB: 0
Revenue Correlation: 90.42 | Revenue CAGR: 5.32% | SUE: -2.72 | # QB: -4
EPS current Quarter (2026-06-30): EPS=0.86 | Chg30d=+0.05% | Revisions=+25% | Analysts=11
EPS next Quarter (2026-09-30): EPS=1.06 | Chg30d=-0.08% | Revisions=+25% | Analysts=11
EPS current Year (2026-12-31): EPS=4.06 | Chg30d=-0.09% | Revisions=+25% | GrowthEPS=+11.5% | GrowthRev=+3.1%
EPS next Year (2027-12-31): EPS=4.61 | Chg30d=-0.02% | Revisions=+25% | GrowthEPS=+13.7% | GrowthRev=+7.2%
[Analyst] Revisions Ratio: +57% (up=4, down=0)